Search

Author/Creator Collinge, Mark

1. Comparative Nonclinical Assessments of the Proposed Biosimilar PF-05280586 and Rituximab (MabThera®). (October 2014)

Authors:
Ryan, Anne M.; Sokolowski, Sharon A.; Ng, Chee-Keng; Shirai, Norimitsu; Collinge, Mark; Shen, Amy C.; Arrington, Joshua; Radi, Zaher; Cummings, Thomas R.; Ploch, Stephen A.; Stephenson, Sarah A.; Tripathi, Niraj K.; Hurst, Susan I.; Finch, Gregory L.; Leach, Michael W.
Journal:
Toxicologic pathology
Issue:
Volume 42:Number 7(2014:Oct.)
Page Start:
1069
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Cross-company evaluation of the human lymphocyte activation assay. Issue 1 (1st January 2020)

Authors:
Collinge, Mark; Schneider, Patricia; Li, Dingzhou; Parish, Stanley; Dumont, Carolyne; Freebern, Wendy; Ghanime, Joseph; Guimont-Derochers, Fanny; Langenkamp, Anja; Lebron, Jose; Li, Nianyu; Marban, Celine; Plitnick, Lisa; Wheeler, Jennifer
Journal:
Journal of immunotoxicology
Issue:
Volume 17:Issue 1(2020)
Page Start:
51
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Current approaches to evaluate the function of cytotoxic T-cells in non-human primates. Issue 1 (31st December 2023)

Authors:
Kamperschroer, Cris; Frank, Brendon; Genell, Caroline; Lebrec, Hervé; Mitchell-Ryan, Shermaine; Molinier, Brigitte; Newsome, Courtni; Piche, Marie-Soleil; Weinstock, Daniel; Collinge, Mark; Freebern, Wendy; Rubio, Daniel
Journal:
Journal of immunotoxicology
Issue:
Volume 20:Issue 1(2023)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗